查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2096953

獸用免疫診斷市場－2026-2032年全球市場預測

Veterinary Immunodiagnostics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫免疫診斷市場將成長至 27.4 億美元，複合年成長率為 8.51%。

主要市場統計數據
基準年 2025 15.4億美元
預計年份：2026年 16.7億美元
預測年份 2032 27.4億美元
複合年成長率 (%) 8.51%

獸醫免疫診斷市場執行摘要

獸醫免疫診斷在現代動物健康中發揮著至關重要的作用，它利用抗原-抗體反應來檢測伴侶動物、家畜、水產養殖動物和野生動物的感染疾病、免疫狀態、生物標記、毒素、荷爾蒙和病原體暴露情況。此領域透過酵素免疫分析法免疫吸附免疫檢測、螢光、化學發光、快速就地檢驗和實驗室血清學平台等技術，為臨床決策、畜牧健康管理、食品安全、抗生素使用和化學冷光病監測提供支援。寵物飼養量的增加、畜牧業生產的通用、跨境動物流動、疫苗接種計劃的擴大以及持續監測人畜共患感染疾病的需求，都推動了該領域的發展。免疫診斷檢測因其擴充性的篩檢、便捷的現場應用以及高通量實驗室確診能力而備受青睞，並被廣泛應用於各種場所，包括私立獸醫院、參考實驗室、農場、政府監測項目和研究機構。隨著動物健康體係日益遵循「同一健康」原則，獸醫免疫診斷正成為早期發現、快速反應和實證疾病管理的基礎工具。

獸醫免疫診斷領域的變革性變化

獸醫免疫診斷領域正從間歇性檢測轉向以預防和監測主導的綜合性動物保健。快速免疫檢測在臨床環境中越來越廣泛的應用，以支持即時分診和治療決策。同時，中心實驗室正轉向多重和自動化平台，以提高檢測的一致性、檢測能力和可追溯性。畜牧養殖戶正在實施將疾病檢測與生物安全、疫苗接種驗證和生產力管理相結合的診斷工作流程，尤其針對影響牛、豬、家禽、小型反芻動物和水產養殖的經濟重要疾病。伴侶動物照護也在不斷發展，獸醫醫院利用免疫診斷試劑盒進行感染疾病篩檢、過敏評估、內分泌監測和健康維護。監管和公共衛生部門的優先事項正在加強檢驗檢測在通用感染疾病監測、進出口證書簽發、食品鏈保障和集體爆發應對中的作用。同時，該領域也關注一些實際限制因素，例如檢體品質、低溫運輸可靠性、檢測靈敏度和特異性、交叉反應、物種特異性檢驗以及對訓練有素人員的需求。這些變化正推動獸醫診斷發展成為一個協調、標準化且易於使用的決策系統，該系統既支持個別動物的治療，也支持群體層面的疾病資訊。

人工智慧對獸醫免疫診斷的累積影響。

人工智慧 (AI) 正在透過改進檢測結果的解讀、品管、整合和回應，變革獸醫免疫診斷。 AI 驅動的影像分析可以輔助螢光的解讀，並減少不同解讀者之間的差異；而機器學習模型則有助於識別血清學、臨床症狀、疫苗接種史、區域因素、季節性和群體層面數據中的診斷模式。在參考實驗室中，AI 可以透過標記不一致的結果和潛在的分析前錯誤，幫助最佳化工作流程、檢測異常情況、確定檢體優先順序並進行品質保證。在現場，AI 驅動的行動應用程式和連網讀卡機可以標準化橫向流動化驗的解讀，最大限度地減少主觀視覺判斷，並增強監測專案的數位化記錄管理。其累積影響不僅限於更快的檢測速度，還包括改進流行病學資訊、制定更有針對性的疫苗接種策略、更早地發現徵兆以及更好地區分感染疾病和非感染疾病病因，從而促進合理使用抗生素。然而，人工智慧的實施需要檢驗的資料集、透明的演算法、網路安全措施、與獸醫資訊系統的互通性以及監管部門的批准。最有前景的應用情境是人工智慧輔助獸醫和診斷專家，而不是取代專家的臨床判斷，尤其是在大規模檢測、人群健康監測以及即時檢測結果標準化方面。

獸醫免疫診斷領域的關鍵區域見解

亞太地區是獸醫免疫診斷的重點區域，這得益於其大規模的牲畜存欄量、不斷擴張的水產養殖業、高密度的家禽和生豬養殖，以及都市區伴侶動物醫療費用支出的不斷成長。該地區反覆出現跨境疾病和通用感染疾病，推動了對快速篩檢、血清學監測和疫苗接種監測的需求，尤其是在集約化肉類生產體系的國家。北美受益於成熟的獸醫檢測基礎設施、便捷的伴侶動物醫療保健服務、完善的牲畜生物安全措施以及協調一致的疾病監測計劃，這些計劃支持即時檢測和參考檢查室檢測。在拉丁美洲，牛、家禽和生豬養殖在經濟中扮演著至關重要的角色，免疫診斷為出口導向動物健康保障、布氏桿菌症和鉤端螺旋體病監測以及不同生產環境下的畜群疾病管理提供了支持。在歐洲，檢驗、標準化和規範化的獸醫診斷方法備受重視，與動物疾病監測、食品安全、降低抗生素抗藥性以及跨境貿易要求密切相關。在中東，對獸醫診斷方法的投資正在增加，以支持糧食安全、駱駝和小反芻動物的健康、馬匹護理以及進口牲畜的監測，尤其注重海灣合作理事會（GCC）國家獸醫服務和檢測能力的現代化。在非洲，迫切需要易於取得、持久耐用且經濟高效的免疫診斷工具，以應對地方性牲畜疾病、野生動物與牲畜的接觸以及通用感染疾病的風險。在檢測設施分佈不均的地區，這種需求尤其迫切，因為現場檢測有助於早期發現和控制疾病。

影響獸醫免疫診斷需求的關鍵群體特定見解

東南亞國協正透過動物疾病監測、畜牧業現代化、水產養殖健康管理以及區域性關注影響家禽、豬、牛和水生生物的跨境疾病風險，加強其獸醫免疫診斷體系。海灣合作理事會（GCC）國家優先發展診斷能力，以支持糧食安全、牲畜進口管制、駱駝健康管理、獵鷹和馬匹醫學以及公共衛生應急準備，因此對既可在中心檢查室使用又可在現場使用的可靠免疫檢測的需求日益成長。歐盟高度重視標準協調、疾病報告、食品鏈安全、動物福利和合理使用抗菌藥物，因此，經過檢驗的免疫診斷測試對於監測、認證和監管合規至關重要。金磚國家面臨多樣化的獸醫診斷需求，涵蓋從大規模畜禽養殖系統到不斷擴大的伴侶動物護理和通用感染疾病監測，因此，各國越來越關注整合國內診斷能力、提供價格合理的檢測方法以及進行數位化監測。七國集團（G7）國家普遍擁有先進的獸醫和檢查室體系，包括完善的自動化免疫檢測平台、高標準的品質保證體系、伴侶動物診斷以及「相同健康」監測框架。雖然北約成員國在獸醫領域並非貿易集團，但它們在生物安全、糧食供應韌性、軍用工作動物健康以及應對生物威脅等方面擁有通用利益，所有這些都凸顯了健全的獸醫免疫診斷基礎設施和可互操作的疾病資訊系統的重要性。

主要國家獸醫免疫診斷的發展趨勢

美國擁有高度發展的獸醫診斷體系，這得益於伴侶動物照護、畜牧生產、強大的獸醫學術網路以及覆蓋全國的疾病監測活動。在加拿大，畜牧生物安全、伴侶動物診斷和食品安全監測已實現有效整合，免疫診斷為畜群健康維護和通用感染疾病監測提供了支持。墨西哥的需求與牛、家禽、豬和伴侶動物的健康保健以及跨境貿易要求密切相關，因此快速且檢驗的檢測在臨床和生產環境中都至關重要。在巴西，大規模的牛、家禽和豬生產產業使得免疫診斷對於疾病監測、出口保障和畜群健康管理至關重要，而伴侶動物診斷在主要都市區市場也持續發展。英國重視伴侶動物健康保健、畜牧疾病監測、獸醫調查和符合監管規定的診斷，並對監測和適當的抗菌藥物管理（AMS）高度關注。在德國、法國、義大利和西班牙，先進的獸醫服務與大規模畜牧業和伴侶動物產業緊密結合，免疫診斷技術被應用於感染疾病檢測、食品安全計畫、預防醫學和疫苗接種監測。在俄羅斯，獸醫診斷需求主要受畜牧業大規模生產、都市區伴侶動物照顧以及對大範圍跨境動物疫病的監測所驅動。在中國，生豬、家禽、水產養殖、伴侶動物和食品安全是主要的需求促進因素，尤其是在大規模動物疫病爆發後，疾病監測工作持續受到重視。在印度，大規模的乳牛養殖場、家禽業、不斷成長的伴侶動物數量以及通用感染疾病的負擔，使得經濟實惠、擴充性且便於現場使用的免疫診斷檢測方法變得尤為重要。日本和韓國擁有先進的獸醫體系，並對伴侶動物診斷、畜牧業生物安全和高品質檢查室檢測有著濃厚的興趣。澳洲對獸醫免疫診斷的需求與牲畜出口保障、生物安全、野生動物健康、伴侶動物醫學以及保護動物健康狀況的監測密切相關。

為獸醫免疫診斷領域的領導者提供實用建議。

產業領導者應優先考慮檢驗的、物種特異性的免疫診斷解決方案，這些方案應在靈敏度、特異性、易用性和現場耐用性之間取得平衡。產品策略應同時滿足高通量檢查室的需求和分散式即時檢測的需求，尤其要注重開發多種檢測方法、數位化領先技術、自動化結果採集以及與獸醫實踐管理和監測系統的整合。製造商和診斷服務提供者應投資於品質保證、外部檢驗、批間一致性以及清晰的結果解讀指南，以建立獸醫、生產者和公共衛生機構的信任。與獸醫學院、參考實驗室、政府動物衛生機構和生產者協會夥伴關係，可以加強檢測方法的檢驗，並加速在實際感染疾病控制環境中的部署。在新興市場和資源有限的市場中，價格合理、低溫運輸可靠性、簡單的樣本製備和培訓支援是關鍵的差異化因素。各組織也應透過支持通用監測、合理使用抗生素、疫苗接種監測和疫情防控，使其服務與「同一健康」的優先事項保持一致。隨著人工智慧和互聯診斷技術的進步，領導者應該從產品設計的早期階段就融入透明的資料管治、網路安全、互通性和臨床醫生參與的工作流程。

獸醫免疫診斷方法分析的調查方法

一套穩健的獸醫免疫診斷評估調查方法應結合二手資料研究、專家一級檢驗和結構化分析三角測量。二手資料研究應利用已驗證的來源，例如同行評審的獸醫期刊、動物健康出版刊物、疾病監測報告、監管指南、檢查室標準、獸醫協會資料、食品安全文件和公共衛生資料庫。一級驗證研究應包括對獸醫、檢查室管理人員、動物衛生官員、畜牧養殖戶、經銷商、學術研究人員和診斷技術專家的訪談，以確定實際檢驗的促進因素和資訊來源。分析評估應按動物種類、技術平台、目標疾病、最終用戶、檢體類型、實驗室環境和地區對研究結果進行分類，同時避免檢驗的假設。應特別注意實驗室性能指標，例如靈敏度、特異性、可重複性、交叉反應性、檢驗狀態、檢體穩定性以及在現場條件下的易用性。調查方法還應納入監管背景、疾病發生模式、疫苗接種實踐、生物安全規程和「同一健康」優先事項。透過多個獨立資訊來源進行交叉檢驗對於確保事實的可靠性、減少偏見以及支持基於證據的策略解讀至關重要。

結論：獸醫免疫診斷的未來

隨著獸醫、生產者、實驗室和公共機構對更早、更快速、更可靠的疾病資訊的需求日益成長，獸醫免疫診斷在動物保健、食品安全和「一體化健康」監測中變得愈發重要。儘管該領域正透過快速即時檢測、自動化檢查室免疫檢測、多重篩檢、連網讀取器和人工智慧驅動的結果解讀等技術不斷進步，但其核心仍是檢驗效能和物種特異性可靠性。各地區的優先事項差異很大，從成熟市場的先進伴侶動物診斷和畜牧生物安全，到新興地區的經濟實惠的現場檢測和跨境疾病控制。在所有情況下，兼具科學可靠性、操作便利性、法規遵循、數位化應對力的解決方案都最有價值。投資於品質、可及性、培訓和綜合監測能力的相關人員將更有利於支持更健康的動物、更安全的食品體系，並增強對通用感染疾病和具有重大經濟影響的動物疾病的防範能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用免疫診斷市場：依產品類型分類

  • 免疫檢測盒
  • 裝置
  • 試劑
    • 抗原和抗體
    • 緩衝液和溶液

第8章 獸用免疫診斷市場：依技術分類

  • 化學冷光免疫檢測
  • ELISA
  • 流式細胞技術
  • 螢光免疫分析
  • 免疫組織化學（IHC）
  • 側向流動免疫檢測
  • 免疫測量（RIA）
  • 蛋白質印跡法

第9章：獸用免疫診斷市場：依動物類型分類

  • 水生動物
  • 伴侶動物
    • 狗
    • 貓
  • 家畜
    • 牛
    • 山羊
    • 家禽
    • 豬

第10章：獸用免疫診斷市場：依通路分類

  • 離線
  • 線上

第11章 獸用免疫診斷市場：依應用領域分類

  • 自體免疫疾病的診斷
  • 癌症診斷
  • 食品安全與品質檢驗
  • 內分泌和代謝疾病的診斷
  • 感染疾病診斷
  • 妊娠和生育能力測試
  • 毒素檢測

第12章 獸用免疫診斷市場：依最終用戶分類

  • 診斷檢查室
  • 製藥和生物技術公司
  • 研究機構
  • 獸醫醫院和診所

第13章 獸用免疫診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 獸用免疫診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 獸用免疫診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agrolabo SpA
  • BioChek BV
  • Biogal Galed Labs
  • Bionote USA Inc.
  • Biopanda Reagents Ltd.
  • Elanco Animal Health
  • FUJIFILM Holdings Corporation
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • LABOKLIN GMBH & CO. KG
  • Neogen Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Co., Ltd.
  • Virbac Animal Health India Pvt. Ltd
  • VolitionRx Limited
  • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market is projected to grow by USD 2.74 billion at a CAGR of 8.51% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.54 billion
Estimated Year [2026] USD 1.67 billion
Forecast Year [2032] USD 2.74 billion
CAGR (%) 8.51%

Veterinary Immunodiagnostics Executive Summary

Veterinary immunodiagnostics plays a critical role in modern animal health by using antigen-antibody reactions to detect infectious diseases, immune status, biomarkers, toxins, hormones, and exposure to pathogens across companion animals, livestock, aquaculture species, and wildlife. The field supports clinical decision-making, herd health management, food safety, antimicrobial stewardship, and zoonotic disease surveillance through technologies such as enzyme-linked immunosorbent assays, lateral flow immunoassays, immunofluorescence assays, chemiluminescent immunoassays, rapid point-of-care tests, and laboratory-based serological platforms. Demand is being shaped by rising pet ownership, intensifying livestock production, cross-border animal movement, expanding vaccination programs, and the continued need to monitor diseases with animal-to-human transmission potential. Immunodiagnostic testing is especially valuable because it can deliver scalable screening, practical field deployment, and high-throughput laboratory confirmation, making it relevant across private veterinary clinics, reference laboratories, farms, government surveillance programs, and research institutions. As animal health systems increasingly align with One Health principles, veterinary immunodiagnostics is becoming a foundational tool for earlier detection, faster response, and more evidence-based disease control.

Transformative Shifts in the Veterinary Immunodiagnostics Landscape

The veterinary immunodiagnostics landscape is shifting from episodic laboratory testing toward integrated, preventive, and surveillance-led animal healthcare. Rapid immunoassays are increasingly used at the point of care to support immediate triage and treatment decisions, while central laboratories are advancing toward multiplex and automated platforms that improve testing consistency, throughput, and traceability. Livestock producers are adopting diagnostic workflows that link disease detection with biosecurity, vaccination verification, and productivity management, particularly for economically significant diseases affecting cattle, swine, poultry, small ruminants, and aquaculture. Companion animal care is also evolving, with veterinary clinics using immunodiagnostic panels for infectious disease screening, allergy evaluation, endocrine monitoring, and wellness-oriented care. Regulatory and public health priorities are strengthening the role of validated assays in zoonotic disease monitoring, import-export certification, food chain assurance, and outbreak response. At the same time, the sector is responding to practical constraints such as sample quality, cold-chain reliability, test sensitivity and specificity, cross-reactivity, species-specific validation, and the need for trained personnel. These shifts are moving veterinary diagnostics toward connected, standardized, and decision-ready systems that support both individual animal treatment and population-level disease intelligence.

Cumulative Impact of AI on Veterinary Immunodiagnostics

Artificial intelligence is beginning to reshape veterinary immunodiagnostics by improving how test results are interpreted, quality-controlled, integrated, and acted upon. AI-enabled image analysis can support immunofluorescence interpretation and reduce reader variability, while machine learning models can help identify diagnostic patterns across serology, clinical signs, vaccination history, geography, seasonality, and herd-level data. In reference laboratories, AI can contribute to workflow optimization, anomaly detection, sample prioritization, and quality assurance by flagging inconsistent results or potential pre-analytical errors. In field settings, AI-supported mobile applications and connected readers can standardize lateral flow assay interpretation, minimize subjective visual reading, and strengthen digital recordkeeping for surveillance programs. The cumulative impact is not limited to faster testing; it also extends to improved epidemiological intelligence, more targeted vaccination strategies, earlier outbreak signals, and better antimicrobial stewardship by distinguishing infectious from non-infectious causes of disease. However, adoption depends on validated datasets, transparent algorithms, cybersecurity safeguards, interoperability with veterinary information systems, and regulatory acceptance. The strongest use cases are emerging where AI augments veterinarians and diagnosticians rather than replacing expert clinical judgment, particularly in high-volume testing, population health surveillance, and point-of-care result standardization.

Key Regional Insights Across Veterinary Immunodiagnostics

Asia-Pacific is a high-priority region for veterinary immunodiagnostics due to its large livestock populations, expanding aquaculture sector, dense poultry and swine production, and increasing companion animal healthcare spending in urban centers. The region's recurring exposure to transboundary and zoonotic diseases has reinforced demand for rapid screening, serosurveillance, and vaccination monitoring, especially in countries with intensive food animal systems. North America benefits from mature veterinary laboratory infrastructure, strong companion animal healthcare utilization, established livestock biosecurity practices, and coordinated disease surveillance programs that support both point-of-care and reference laboratory testing. Latin America is shaped by the economic importance of cattle, poultry, and swine production, with immunodiagnostics supporting export-oriented animal health assurance, brucellosis and leptospirosis monitoring, and herd-level disease control across diverse production environments. Europe emphasizes validated, standardized, and regulation-aligned veterinary diagnostics, with strong links between animal disease monitoring, food safety, antimicrobial resistance reduction, and cross-border trade requirements. The Middle East is investing in veterinary diagnostics to support food security, camel and small ruminant health, equine care, and imported livestock monitoring, with GCC countries particularly focused on modernization of veterinary services and laboratory capacity. Africa presents a critical need for accessible, rugged, and cost-effective immunodiagnostic tools to address endemic livestock diseases, wildlife-livestock interfaces, and zoonotic risks, especially where laboratory access is uneven and field-deployable testing can improve early detection and control.

Key Group Insights Shaping Veterinary Immunodiagnostics Demand

ASEAN countries are strengthening veterinary immunodiagnostics through animal disease surveillance, livestock modernization, aquaculture health management, and regional attention to transboundary disease risks that affect poultry, swine, cattle, and aquatic species. GCC countries are prioritizing diagnostic capacity in support of food security, livestock import controls, camel health, falconry and equine medicine, and public health preparedness, creating demand for reliable immunoassays that function in both centralized laboratories and field conditions. The European Union places strong emphasis on harmonized standards, disease notification, food chain safety, animal welfare, and antimicrobial stewardship, making validated immunodiagnostic tests important for surveillance, certification, and regulatory compliance. BRICS countries collectively represent diverse veterinary diagnostic needs, from large-scale livestock and poultry systems to growing companion animal care and zoonotic disease monitoring, with increasing interest in domestic diagnostic capability, affordable testing, and digital surveillance integration. G7 countries generally operate advanced veterinary healthcare and laboratory ecosystems, where automated immunoassay platforms, high-quality assurance standards, companion animal diagnostics, and One Health surveillance frameworks are well established. NATO countries, while not a veterinary trade bloc, have shared interests in biosecurity, food supply resilience, military working animal health, and preparedness against biological threats, all of which support the value of robust veterinary immunodiagnostic infrastructure and interoperable disease intelligence systems.

Key Country Insights in Veterinary Immunodiagnostics

The United States has a highly developed veterinary diagnostics environment supported by companion animal care, livestock production, academic veterinary networks, and national disease surveillance activities. Canada combines strong livestock biosecurity, companion animal diagnostics, and food safety oversight, with immunodiagnostics supporting herd health and zoonotic disease monitoring. Mexico's needs are closely linked to cattle, poultry, swine, companion animal medicine, and cross-border trade requirements, making rapid and validated tests valuable for both clinical and production settings. Brazil's large cattle, poultry, and swine sectors make immunodiagnostics essential for disease surveillance, export assurance, and herd health management, while companion animal diagnostics continue to expand in major urban markets. The United Kingdom emphasizes companion animal medicine, livestock disease monitoring, veterinary research, and regulatory-aligned diagnostics, with strong interest in surveillance and antimicrobial stewardship. Germany, France, Italy, and Spain each combine advanced veterinary services with significant livestock and companion animal sectors, using immunodiagnostics for infectious disease detection, food safety programs, preventive healthcare, and vaccination monitoring. Russia's veterinary diagnostic needs are shaped by extensive livestock production, companion animal care in urban centers, and surveillance for transboundary animal diseases across a broad geography. China has major demand drivers in swine, poultry, aquaculture, companion animals, and food safety, with continued focus on disease monitoring after major animal disease outbreaks. India's large dairy population, poultry sector, companion animal growth, and zoonotic disease burden create a strong need for affordable, scalable, and field-ready immunodiagnostic testing. Japan and South Korea maintain sophisticated veterinary healthcare systems with strong interest in companion animal diagnostics, livestock biosecurity, and high-quality laboratory testing. Australia's veterinary immunodiagnostics demand is tied to livestock export assurance, biosecurity, wildlife health, companion animal medicine, and surveillance designed to protect its animal health status.

Actionable Recommendations for Veterinary Immunodiagnostics Leaders

Industry leaders should prioritize validated, species-specific immunodiagnostic solutions that balance sensitivity, specificity, ease of use, and field durability. Product strategies should address both high-throughput laboratory needs and decentralized point-of-care testing, with particular attention to multiplex assay development, digital readers, automated result capture, and integration with veterinary practice management or surveillance systems. Manufacturers and diagnostic service providers should invest in quality assurance, external validation, lot-to-lot consistency, and clear interpretation guidance to build trust among veterinarians, producers, and public health authorities. Partnerships with veterinary schools, reference laboratories, government animal health agencies, and producer groups can strengthen assay validation and accelerate adoption in practical disease-control settings. For emerging and resource-constrained markets, affordability, cold-chain resilience, simple sample preparation, and training support are essential differentiators. Organizations should also align offerings with One Health priorities by supporting zoonotic disease surveillance, antimicrobial stewardship, vaccination monitoring, and outbreak preparedness. As artificial intelligence and connected diagnostics advance, leaders should build transparent data governance, cybersecurity, interoperability, and clinician-in-the-loop workflows into product design from the outset.

Research Methodology for Veterinary Immunodiagnostics Analysis

A robust research methodology for assessing veterinary immunodiagnostics should combine secondary research, primary expert validation, and structured analytical triangulation. Secondary research should draw from verified sources such as peer-reviewed veterinary journals, animal health agency publications, disease surveillance reports, regulatory guidance, laboratory standards, veterinary association materials, food safety documentation, and public health databases. Primary research should include interviews with veterinarians, laboratory directors, animal health officials, livestock producers, distributors, academic researchers, and diagnostic technology specialists to capture practical adoption drivers and barriers. Analytical evaluation should segment insights by animal type, technology platform, disease application, end user, sample type, testing setting, and geography, while avoiding unverified assumptions. Special attention should be given to assay performance metrics such as sensitivity, specificity, reproducibility, cross-reactivity, validation status, sample stability, and usability under field conditions. The methodology should also incorporate regulatory context, disease occurrence patterns, vaccination practices, biosecurity protocols, and One Health priorities. Cross-validation across multiple independent sources is essential to ensure factual reliability, reduce bias, and support evidence-based strategic interpretation.

Conclusion: The Future of Veterinary Immunodiagnostics

Veterinary immunodiagnostics is becoming increasingly central to animal healthcare, food safety, and One Health surveillance as veterinarians, producers, laboratories, and public agencies seek earlier, faster, and more reliable disease intelligence. The sector is advancing through rapid point-of-care tests, automated laboratory immunoassays, multiplex screening, connected readers, and AI-supported interpretation, while remaining grounded in the need for validated performance and species-specific reliability. Regional priorities vary, from advanced companion animal diagnostics and livestock biosecurity in mature markets to affordable field testing and transboundary disease control in emerging regions. Across all settings, the most valuable solutions are those that combine scientific credibility, operational practicality, regulatory alignment, and digital readiness. Stakeholders that invest in quality, accessibility, training, and integrated surveillance capabilities will be best positioned to support healthier animals, safer food systems, and stronger preparedness against zoonotic and economically significant animal diseases.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Immunodiagnostics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Immunoassay Kits
  • 7.3. Instruments
  • 7.4. Reagents
    • 7.4.1. Antigens & Antibodies
    • 7.4.2. Buffers & Solutions

8. Veterinary Immunodiagnostics Market, by Technology

  • 8.1. Introduction
  • 8.2. Chemiluminescence Immunoassays
  • 8.3. ELISA
  • 8.4. Flow Cytometry
  • 8.5. Fluorescence Immunoassays
  • 8.6. Immunohistochemistry (IHC)
  • 8.7. Lateral Flow Immunoassays
  • 8.8. Radioimmunoassay (RIA)
  • 8.9. Western Blotting

9. Veterinary Immunodiagnostics Market, by Animal Type

  • 9.1. Introduction
  • 9.2. Aquatic Animals
  • 9.3. Companion Animals
    • 9.3.1. Canine
    • 9.3.2. Feline
  • 9.4. Livestock Animals
    • 9.4.1. Cattle
    • 9.4.2. Goats
    • 9.4.3. Poultry
    • 9.4.4. Swine

10. Veterinary Immunodiagnostics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Veterinary Immunodiagnostics Market, by Application

  • 11.1. Introduction
  • 11.2. Autoimmune Disease Diagnostics
  • 11.3. Cancer Diagnostics
  • 11.4. Food Safety & Quality Testing
  • 11.5. Hormonal & Metabolic Disorder Diagnostics
  • 11.6. Infectious Disease Diagnostics
  • 11.7. Pregnancy & Fertility Testing
  • 11.8. Toxin Detection

12. Veterinary Immunodiagnostics Market, by End User

  • 12.1. Introduction
  • 12.2. Diagnostic Laboratories
  • 12.3. Pharmaceutical & Biotechnology Companies
  • 12.4. Research Institutes
  • 12.5. Veterinary Clinics & Hospitals

13. Veterinary Immunodiagnostics Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Veterinary Immunodiagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Immunodiagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agrolabo S.p.A.
  • 17.2. BioChek BV
  • 17.3. Biogal Galed Labs
  • 17.4. Bionote USA Inc.
  • 17.5. Biopanda Reagents Ltd.
  • 17.6. Elanco Animal Health
  • 17.7. FUJIFILM Holdings Corporation
  • 17.8. GD Animal Health
  • 17.9. Heska Corporation
  • 17.10. IDEXX Laboratories, Inc.
  • 17.11. INDICAL BIOSCIENCE GmbH
  • 17.12. Innovative Diagnostics SAS
  • 17.13. LABOKLIN GMBH & CO. KG
  • 17.14. Neogen Corporation
  • 17.15. Randox Laboratories Ltd.
  • 17.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.17. Thermo Fisher Scientific Inc.
  • 17.18. URIT Medical Electronic Co., Ltd.
  • 17.19. Virbac Animal Health India Pvt. Ltd
  • 17.20. VolitionRx Limited
  • 17.21. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOASSAY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOASSAY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMMUNOASSAY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIGENS & ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTIGENS & ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIGENS & ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BUFFERS & SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUFFERS & SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BUFFERS & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IMMUNOHISTOCHEMISTRY (IHC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNOHISTOCHEMISTRY (IHC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY (IHC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LATERAL FLOW IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LATERAL FLOW IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LATERAL FLOW IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIOIMMUNOASSAY (RIA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIOIMMUNOASSAY (RIA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIOIMMUNOASSAY (RIA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WESTERN BLOTTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WESTERN BLOTTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WESTERN BLOTTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CANINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FELINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FELINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FELINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOOD SAFETY & QUALITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOOD SAFETY & QUALITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOOD SAFETY & QUALITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HORMONAL & METABOLIC DISORDER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HORMONAL & METABOLIC DISORDER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HORMONAL & METABOLIC DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PREGNANCY & FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PREGNANCY & FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PREGNANCY & FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOXIN DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TOXIN DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TOXIN DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 193. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA VETERINARY